Glenmark Pharmaceuticals has informed that it enclosed a copy of press release regarding - Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize''s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal.
The above information is a part of company’s filings submitted to BSE.